Sign up to save your podcasts
Or
Share SPECIAL REPORT on Aducanumab Approval: Steve Pearson of ICER Discusses the Economic and Clinical Impact
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
SPECIAL REPORT on Aducanumab Approval: Steve Pearson of ICER Discusses the Economic and Clinical Impact
Dr. Jason Crowell speaks with Dr. Steve Pearson, President of the Institute for Clinical and Economic Review, about the clinical and economic impact of aducanumab, a drug recently approved by the FDA for the treatment of Alzheimer disease.
View all episodes
By American Academy of Neurology
4.7
272272 ratings
Dr. Jason Crowell speaks with Dr. Steve Pearson, President of the Institute for Clinical and Economic Review, about the clinical and economic impact of aducanumab, a drug recently approved by the FDA for the treatment of Alzheimer disease.
More shows like Neurology® Podcast
View all
JAMA Editors' Summary
130 Listeners
NEJM This Week
324 Listeners
Practical Neurology Podcast
45 Listeners
JAMA Clinical Reviews
493 Listeners
The Curbsiders Internal Medicine Podcast
3,323 Listeners
JAMA Neurology Author Interviews
14 Listeners
Core IM | Internal Medicine Podcast
1,086 Listeners
Neurology Today in 5
21 Listeners
Annals On Call Podcast
185 Listeners
The Clinical Problem Solvers
515 Listeners
Neurology Minute
132 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
348 Listeners
Neurology Exam Prep Podcast
182 Listeners
The Curious Clinicians
366 Listeners
Continuum Audio
78 Listeners